Latest News
Solventum Corporation
- Solventum Corporation Estimates – NYSE:SOLV
- Solventum Unveils Next-Generation Filtek Matrix Restorative System
- Solventum’s FDA Nod Combines Tissue Scaffold with Negative Pressure Therapy
- Solventum gets FDA clearance for combined wound care therapy By Investing.com
- FDA Clears Combined Use of Restrata Matrix With Solventum V.A.C. Therapy
- Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
- Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
- Solventum gets FDA clearance for combined wound care therapy By Investing.com
- Solventum Corp. stock falls Friday, underperforms market
- Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
- Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
- Solventum collecting offers for Health Information Systems Business - Axios Pro
Headlines from the last 30 days, linking to the original publishers. See all market news →